CGEM
Cullinan Therapeutics, Inc.
+0.69 (+3.34%)21.32USD183K成交股數1.4B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-14下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 44.4M | 42.1M | 42.0M | 61.0M | 41.5M | 40.5M | 35.5M | 36.3M | 30.6M | 33.8M | 27.4M | 52.1M |
| 銷售管理費用 | 12.8M | 11.6M | 13.6M | 14.8M | 13.5M | 14.6M | 13.3M | 13.8M | 12.3M | 11.0M | 10.2M | 10.7M |
| 營業利益 | −57.3M+4% | −53.7M-2% | −55.6M+14% | −75.8M+52% | −55.0M+28% | −55.0M+22% | −48.9M+30% | −50.0M-20% | −43.0M | −45.2M | −37.6M | −62.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −53.7M+11% | −49.7M+4% | −50.6M+25% | −70.1M+67% | −48.5M+31% | −47.8M+22% | −40.6M+26% | −42.0M-27% | −37.1M | −39.2M | −32.2M | −58.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | -0.69-16% | -0.75-47% | -0.86 | -0.91 | -0.82 | -1.42 |
| 稀釋股數 | – | – | – | – | – | – | 58.3M | 55.1M | 43.0M | 42.7M | 40.0M | 40.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 78.6M | 75.1M | 103M | 72.8M | 76.7M | 83.0M | 102M | 115M | 74.2M | 64.8M | 142M | 122M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 364M | 403M | 484M | 520M | 580M | 622M | 653M | 681M | 449M | 495M | 522M | 515M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 42.0M | 36.8M | 32.8M | 28.2M | 27.8M | 31.5M | 25.4M | 25.0M | 23.8M | 25.9M | 22.4M | 29.3M |
| 股東權益 | 322M | 366M | 451M | 492M | 552M | 590M | 628M | 656M | 426M | 469M | 500M | 486M |
| 負債比 | 11.6% | 9.1% | 6.8% | 5.4% | 4.8% | 5.1% | 3.9% | 3.7% | 5.3% | 5.2% | 4.3% | 5.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −46.0M | – | – | −43.2M+13% | – | – | – | −38.2M | – | – | −51.0M |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | 159K |
| 自由現金流 | – | – | – | – | – | – | – | – | −38.2M | – | – | −51.2M |
| 折舊攤銷 | – | 79K | – | – | 76K | – | – | – | 76K | – | – | 72K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −220M | –% | – | −176M |
| FY2024 | – | – | −168M | –% | – | −145M |
| FY2023 | – | – | −155M | –% | -3.69 | −134M |
| FY2022 | 0.00 | -100.0% | 111M | –% | 2.38 | −128M |
| FY2021 | 18.9M | – | −65.6M | -346.1% | -1.52 | −43.4M |
| FY2020 | 0.00 | – | −51.8M | –% | -2.60 | −29.8M |